Pfreundschuh M - Search Results

1

Anti-idiotype vaccine against Hodgkin's lymphoma: induction of B- and T-cell immunity across species barriers against CD30 antigen by murine monoclonal internal image antibodies.

Pohl C, Renner C, Schwonzen M, Sieber M, Lorenz P, Pfreundschuh M, Diehl V. Pohl C, et al. Among authors: pfreundschuh m. Int J Cancer. 1992 Apr 1;50(6):958-67. doi: 10.1002/ijc.2910500623. Int J Cancer. 1992. PMID: 1313400

2

Treatment of refractory Hodgkin's disease with an anti-CD16/CD30 bispecific antibody.

Renner C, Hartmann F, Pfreundschuh M. Renner C, et al. Among authors: pfreundschuh m. Cancer Immunol Immunother. 1997 Nov-Dec;45(3-4):184-6. doi: 10.1007/s002620050428. Cancer Immunol Immunother. 1997. PMID: 9435869 Free PMC article. Clinical Trial.

3

Idiotype vaccine against Hodgkin's lymphoma: generation and characterization of an anti-idiotypic monoclonal antibody against the Hodgkin-associated (anti-CD 30) monoclonal antibody HRS-3.

Pohl C, Sieber M, Diehl V, Pfreundschuh M. Pohl C, et al. Among authors: pfreundschuh m. Anticancer Res. 1991 May-Jun;11(3):1115-24. Anticancer Res. 1991. PMID: 1653553

4

Detection of a soluble form of the CD30 antigen in sera of patients with lymphoma, adult T-cell leukemia and infectious mononucleosis.

Pfreundschuh M, Pohl C, Berenbeck C, Schroeder J, Jung W, Schmits R, Tschiersch A, Diehl V, Gause A. Pfreundschuh M, et al. Int J Cancer. 1990 May 15;45(5):869-74. doi: 10.1002/ijc.2910450515. Int J Cancer. 1990. PMID: 2159438

5

Specific activation of the prodrug mitomycin phosphate by a bispecific anti-CD30/anti-alkaline phosphatase monoclonal antibody.

Sahin U, Hartmann F, Senter P, Pohl C, Engert A, Diehl V, Pfreundschuh M. Sahin U, et al. Among authors: pfreundschuh m. Cancer Res. 1990 Nov 1;50(21):6944-8. Cancer Res. 1990. PMID: 2170012

6

Mimicry of the Hodgkin-associated IRAC antigen by an anti-idiotype network: potential use in active immunotherapy of Hodgkin's lymphoma.

Schobert I, Renner C, Pfreundschuh M, Diehl V, Pohl C. Schobert I, et al. Among authors: pfreundschuh m. Leuk Lymphoma. 1994 May;13(5-6):429-40. doi: 10.3109/10428199409049632. Leuk Lymphoma. 1994. PMID: 8069188

7

A CD16/CD30 bispecific monoclonal antibody induces lysis of Hodgkin's cells by unstimulated natural killer cells in vitro and in vivo.

Hombach A, Jung W, Pohl C, Renner C, Sahin U, Schmits R, Wolf J, Kapp U, Diehl V, Pfreundschuh M. Hombach A, et al. Among authors: pfreundschuh m. Int J Cancer. 1993 Nov 11;55(5):830-6. doi: 10.1002/ijc.2910550523. Int J Cancer. 1993. PMID: 8244580

8

CD30-specific AB1-AB2-AB3 internal image antibody network: potential use as anti-idiotype vaccine against Hodgkin's lymphoma.

Pohl C, Renner C, Schwonzen M, Schobert I, Liebenberg V, Jung W, Wolf J, Pfreundschuh M, Diehl V. Pohl C, et al. Among authors: pfreundschuh m. Int J Cancer. 1993 May 28;54(3):418-25. doi: 10.1002/ijc.2910540312. Int J Cancer. 1993. PMID: 8389737

9

Active specific immunotherapy of Hodgkin's lymphoma by an anti-idiotype vaccine against the Hodgkin-associated CD30 antigen.

Renner C, Pfreundschuh M, Diehl V, Pohl C. Renner C, et al. Among authors: pfreundschuh m. Ann N Y Acad Sci. 1993 Aug 12;690:352-4. doi: 10.1111/j.1749-6632.1993.tb44028.x. Ann N Y Acad Sci. 1993. PMID: 8396378 No abstract available.

10

Anti-CD16/CD30 bispecific antibodies as possible treatment for refractory Hodgkin's disease.

Hartmann F, Renner C, Jung W, Pfreundschuh M. Hartmann F, et al. Among authors: pfreundschuh m. Leuk Lymphoma. 1998 Oct;31(3-4):385-92. doi: 10.3109/10428199809059232. Leuk Lymphoma. 1998. PMID: 9869203 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

524 results

Search Page

Filters